Live Breaking News & Updates on Kras g12c and chemotherapy

Lyudmila A. Bazhenova, MD, discusses potential combination strategies with KRAS G12C inhibitors in advanced non–small cell lung cancer.

Lyudmilaa-bazhenova , Potential-combination-strategies-with , California-san-diego-moores-cancer-center , Adagrasib , Sotorasib , Kras-g12c-mutant-non-small-cell-lung-cancer , Shp2-inhibitors , Sos1-inhibitors , Scarlet-trial- , Kras-g12c-and-chemotherapy , Kras-g12c-and-immunotherapy